Table 1.
N |
NY-ESO Positive |
NY-ESO negative |
||
---|---|---|---|---|
Synovial saicomma | 50 | 41 (82%) | 9 | |
GISTs | 155 | 2 (1%) | 153 | P<0.0001 |
Lei omyo sarcoma | 24 | 0 (0%) | 24 | P<0.0001 |
MPNST | 1 (3%) | 33 | P<0.0001 | |
SFT | 40 | 0 (0%) | 40 | P<0.0001 |
Cellular | 0 (0%) | P<0.0001 | ||
schwannoma | ||||
DFSP | 20 | 2 (10%) | P<0.0001 | |
Angio sarcoma | 20 | 2 (10%) | i | P<0.0001 |
Ewing sarcoma | 18 | 0 (0%) | 18 | P<0.0001 |
Malignant | 0 (0%) | 27 | P<0.0001 | |
Other sarcomasa | 12 | 3 | 9 | P = 0.0003 |
Abbreviations: GIST: gastrointestinal stromal tumor; MPNST: malignant peripheral nerve sheath tumor; SFT: hemangiopericytoma/solitary fibrous tumor; DFSP: dermatofibrosarcoma protuberans.
aOthers sarcoma includes osteosarcoma (0/4), chondrosarcoma (1/2), dedifferentiated liposarcoma (1/1), alveolar soft part sarcoma (0/1), undifferentiated sarcoma (1/1), high-grade spindle cell sarcoma (0/2) and rhabdomyosarcoma (0/1).